drugset / Trial / NCT01486940

Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 Diabetes

NCT01486940

Phase 3 Completed 598 enrolled Novo Nordisk A/S
RandomizedParallel-groupOpen-labelTreatment

Summary

This trial is conducted in Europe and South America. The aim of this trial is to compare the glycaemic control of insulin detemir plus insulin aspart with that of insulin NPH plus human soluble insulin in subjects with type 1 diabetes on a basal/bolus regimen.

Timeline

Start
2002-03
Primary completion
2002-10
Completion
2002-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator human soluble insulin Protein / enzyme biologic Subcutaneous
Comparator insulin NPH Protein / enzyme biologic Subcutaneous
Subject insulin aspart Protein / enzyme biologic Subcutaneous
Subject insulin detemir Protein / enzyme biologic Subcutaneous